Citadel Advisors - GLYCOMIMETICS INC ownership

GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 80 filers reported holding GLYCOMIMETICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of GLYCOMIMETICS INC
ValueSharesWeighting
Q2 2023$52,830
-76.6%
30,362
-83.0%
0.00%
Q1 2023$225,414
-58.2%
178,900
+0.5%
0.00%
Q4 2022$539,407
+8890.1%
178,022
+1549.0%
0.00%
Q2 2022$6,000
-83.8%
10,796
-67.0%
0.00%
Q1 2022$37,000
-90.4%
32,719
-87.8%
0.00%
Q4 2021$384,000
-46.4%
267,475
-18.1%
0.00%
Q3 2021$716,000
-27.2%
326,664
-23.0%
0.00%
Q2 2021$983,000
+36.1%
424,115
+76.8%
0.00%
Q1 2021$722,000
-8.3%
239,843
+14.6%
0.00%
Q4 2020$787,000
+44.4%
209,204
+17.8%
0.00%
Q3 2020$545,000
-44.5%
177,578
-32.0%
0.00%
Q2 2020$982,000
+136.6%
261,205
+43.4%
0.00%
Q1 2020$415,000
-70.9%
182,123
-32.4%
0.00%
-100.0%
Q4 2019$1,425,000
-20.3%
269,468
-35.1%
0.00%0.0%
Q3 2019$1,788,000
-60.3%
415,015
+9.8%
0.00%
-50.0%
Q2 2019$4,505,000
-51.9%
377,958
-49.7%
0.00%
-60.0%
Q1 2019$9,360,000
+24.1%
751,165
-5.7%
0.01%
+25.0%
Q4 2018$7,545,000
-38.4%
796,747
-6.3%
0.00%
-20.0%
Q3 2018$12,241,000
-47.8%
850,069
-41.5%
0.01%
-58.3%
Q2 2018$23,438,000
+21.7%
1,453,077
+22.4%
0.01%
+20.0%
Q1 2018$19,262,000
+177.7%
1,186,853
+187.3%
0.01%
+150.0%
Q4 2017$6,937,000
+749.1%
413,119
+607.1%
0.00%
+300.0%
Q3 2017$817,000
+228.1%
58,422
+161.9%
0.00%
Q2 2017$249,00022,3110.00%
Other shareholders
GLYCOMIMETICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
BVF INC/IL 7,361,801$31,729,0003.33%
NEA Management Company, LLC 9,089,041$39,174,0003.24%
Camber Capital Management LP 3,500,000$15,085,0000.79%
Redmile Group, LLC 1,997,647$8,610,0000.29%
Alambic Investment Management, L.P. 41,698$180,0000.14%
CAXTON CORP 26,575$115,0000.13%
PRENTISS SMITH & CO INC 17,000$73,0000.05%
Virtus ETF Advisers LLC 22,580$97,0000.02%
AXA S.A. 1,825,738$7,868,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 30,000$129,0000.01%
View complete list of GLYCOMIMETICS INC shareholders